heartmatters by Boston Heart Boston Heart Diagnostics

Join Ernst J. Schaefer, MD, Founder and Chief Medical Officer as he introduces LipidSeq TM, a revolutionary genetic test for cardiovascular disease. This saliva-based Next Generation Sequencing (NGS) test identifies the most common genetic causes of lipid and lipoprotein disorders. These disorders are associated with premature cardiovascular, pancreatic, kidney, and neurological diseases.
Click Here to Learn More

Join Ernst J. Schaefer, MD, Founder and Chief Medical Officer as he discusses the Boston Heart Polygenic Risk Map™. These genetic tests leverage Polygenic Risk Scores (PRS) to provide physicians with a much more precise understanding of their patient’s absolute genetic risk of complex disease, allowing for the creation of early, personalized intervention strategies.

Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he introduces Boston Heart’s dried blood spot testing program. Dried blood spots are an innovative sampling technique using drops of blood, from a fingertip, dried onto a special paper. Blood can be collected at home and shipped to the laboratory. When obtaining venous blood is not a viable option, dried blood spot testing may be the perfect solution! More than 40 tests are now available.
Providers can visit https://bostonheartdiagnostics.com/ProvDBS for more information
Patients can visit https://bostonheartdiagnostics.com/PatDBS for more information

Join Dr. Ernst Schaefer (Boston Heart's Co-founder, Chief Medical Officer, and Lab Director) as he discusses the foundations of Boston Heart's new LipoMapTM test based on NMR testing. He provides an overview of cholesterol metabolism and how recent advances in NMR technology have enabled Boston Heart to provide the most comprehensive assessment of lipoproteins and cholesterol metabolism available to practicing clinicians.

Join Dr. Issvoran as he discusses how a national focus to minimize dietary fat during the latter half of the 20th century led to unchecked increases in refined sugars and starches. This unintended consequence in turn fueled increases in obesity and type 2 diabetes and slowed progress with heart disease prevention.

Join Michael Dansinger, MD, Vice President of Clinical Affairs, as he discusses how Boston Heart provides a systematic approach to identifying and reversing key aspects of the atherosclerosis process. Viewers will gain a better understanding of the evidence base and clinical rationale for specialized cardiometabolic testing, and how Boston Heart empowers clinicians to proactively unmask disease and personalize patient treatment like nobody else.
 
For more information please visit https://bostonheartdiagnostics.com